Skip to main content
OpenTrials
Completed

NCT Number: NCT00629070

Quadriceps Muscle Plasticity in Children With Cerebral Palsy

Our primary aim is to determine whether and how muscle architecture of the quadriceps muscles in cerebral palsy (CP) adapts to two separate training programs: traditional strength training (ST) vs. velocity-enhanced training (VT). For the ST group, we hypothesize that muscle size will increase in conjunction with strength. For the VT group, in addition to the above, we hypothesize that fiber length will increase with measures of muscle power. We also hypothesize that walking velocity will improve in both groups but that knee motion and step length will improve only with VT.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Neuromuscular Assessment Laboratory

Charleston, South Carolina, 29414, United States

About this study

Cerebral palsy (CP) is the most common physical disability originating in childhood, occurring in 2-3 per 1,000 live births. Although the primary deficit in CP is injury to the brain, secondary impairments affecting muscle function such as weakness, contractures, and spasticity are often far more debilitating and lead to worsening disability throughout the lifespan. Some have suggested that these muscle changes in CP may be irreversible; however, it is now known that muscles are one of the most 'plastic' tissues in the body. In fact, recent evidence suggests that gross muscle hypertrophy and architectural changes within muscle fibers can occur as early as 3-5 weeks after resistance training in healthy adults. It is also unknown how effectively muscles in CP can adapt to training stimuli that target specific muscle architectural parameters, such as fascicle length and cross-sectional area. These parameters have been observed to be decreased in CP, suggesting loss of sarcomeres in-series (fiber shortening) and in-parallel (muscle atrophy). We propose here that specific training-induced muscle architectural adaptations can occur in CP, leading to improved motor function.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of cerebral palsy
  • Gross motor function classification system levels I, II, or III
  • Ages 7 to 17

Exclusion criteria

  • Orthopedic or neurosurgery within the past year
  • Botulinum toxin injections within the 4 months prior to the study

Treatment and study plan

Traditional Strength Training

Other

Performed 3 x week for 8 weeks on an isokinetic dynamometer (knee extension exercise)at 30 degrees/second; 6 sets of 5 maximum-effort concentric actions

Velocity-enhanced training

Other

Performed 3 x week for 8 weeks on an isokinetic dynamometer (knee extension exercise). Subjects will perform 2 sets of 5 concentric exertions at 30°/second. The following 4 sets of 5 repetitions will be performed at a faster speed, starting at 60° /second. The velocity will be increased weekly in 15° /second increments up to a maximum of 120°/second.

Primary outcomes

  1. Muscle thickness

    Time frame: before and after intervention

Secondary outcomes

  1. Fascicle length

    Time frame: before and after intervention

  2. Muscle strength (peak torque)

    Time frame: before and after intervention

  3. Muscle power

    Time frame: before and after intervention

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Registry information

Official study title

In Vivo Assessment of Quadriceps Muscle Plasticity in Children With Cerebral Palsy

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Mar 5, 2008
Registry last updated
May 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.